We revealed that: (i) NFT stages were higher in patients with BD compared with controls, (ii) late‐onset BD cases showed a higher prevalence of AD‐type pathology compared with early‐onset BD cases, and (iii) presence of CHMP2B‐positive GVD in the PVT in patients with BD. Here, CHMP2B is linked to Alzheimer disease.